On 22nd May 2025 the EBN presented at the OncoSafe Conference in Romanian Parliament, Bucharest. This was an educational conference dedicated to improving safety practices in the handling and administration of cytostatics, cytotoxics and other CMR hazardous substances collectively… Read more
News
The EBN, in partnership with the KOK, Launches Landmark Survey to Improve Safety for Oncology Nurses in Germany
2 April, 2025 Today, the EBN, in partnership with the Konferenz Onkologischer Kranken- und Kinderpflege (KOK), or German Oncology Nursing Association, has launched a landmark survey examining how German oncology nurses handle hazardous medicinal products (HMPs). The KOK… Read more
The European Biosafety Network presents at the Safer Cancer Care Conference, Brussels
On 7 March 2025, the European Biosafety Network (EBN) participated in the Safer Cancer Care Conference in Brussels, joining a distinguished panel of speakers, healthcare professionals, researchers, and policymakers. The event centred on a critical goal: raising awareness… Read more
The EU Commission publishes a European List of Hazardous Medicinal Products, Based on ETUI Research
Hazardous medicinal products (HMPs)—including many anti-cancer agents, antivirals, and immunosuppressants—are integral to treating serious diseases but can also pose risks to healthcare professionals. These drugs can cause cancer or reproductive disorders in exposed workers, underlining the urgent need for… Read more
BJN – Protecting workers from contamination and exposure to hazardous medicinal products and the potential health effects
Screenshot… Read more
EBN Secretary Ian Lindsley presents at ‘The Future of Automated Compounding’ in Łódź, Poland
The Future of Automated Compounding was held in the Puro Hotel, Łódź on 8-9 June 2024, attended by pharmacists from all over Poland. Ian Lindsley’s presentation focused on the EBN white paper on ‘Preventing contamination, exposure and health… Read more
Millions of healthcare workers get protection from new EU law today
From today’s date, millions of workers (mostly women) in Europe will be protected for the first time by EU and national law from the impact of regular exposure in the workplace to potentially life-threatening hazardous drugs – hazardous medicinal… Read more
Joint Summit: Preventing occupational exposure to Hazardous Medicinal Products (HMPs)
30th January 2024, 9.30am to 3pm, at Fórsa, Dublin A joint Summit on preventing occupational exposure to Hazardous Medicinal Products (HMPs) was held at Fórsa’s office in Dublin on 30th January 2024, hosted by Fórsa, the European Biosafety… Read more
EBN to host Joint Summit on Preventing occupational exposure to Hazardous Medicinal Products
On Tuesday 30 January, 10am-3pm, Fórsa and the European Biosafety Network (EBN), in association with the Hospital Pharmacists Association of Ireland and the National Association of Hospital Pharmacy Technicians, are hosting a one-day Joint Summit in Dublin. The summit… Read more
Further protection for workers and healthcare professionals approved by European Parliament today
The Stop Cancer at Work coalition welcomes the overwhelming vote today in the Employment Committee of the European Parliament for better protection for workers and healthcare professionals from potentially life-threatening hazardous medicinal products (HMPs). The campaign urges the European… Read more
